Actinium Pharmaceuticals Stock Analysis

Actinium Stock Analysis Notes

About 30.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.18. Some equities with similar Price to Book (P/B) outperform the market in the long run. Actinium Pharmaceuticals recorded a loss per share of 1.39. The entity last dividend was issued on the 11th of August 2020. The firm had 1:30 split on the 11th of August 2020. Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant or a type of cellular therapy, and for other adoptive cell therapies. The company was incorporated in 2000 and is based in New York, New York. Actinium Pharmaceuticals operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 32 people. For more info on Actinium Pharmaceuticals please contact MS MBA at 646 677 3870 or go to https://www.actiniumpharma.com.

Actinium Pharmaceuticals Investment Alerts

Actinium Pharmaceuticals Upcoming and Recent Events

Actinium Largest EPS Surprises

View All Earnings Estimates

Actinium Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 44.92 M.

Actinium Profitablity

Management Efficiency

Actinium Pharmaceuticals has return on total asset (ROA) of (0.3091) % which means that it has lost $0.3091 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8796) %, meaning that it created substantial loss on money invested by shareholders. Actinium Pharmaceuticals' management efficiency ratios could be used to measure how well Actinium Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of the 30th of November 2024, Return On Tangible Assets is likely to grow to -0.57. In addition to that, Return On Capital Employed is likely to grow to -0.68. At this time, Actinium Pharmaceuticals' Total Assets are very stable compared to the past year. As of the 30th of November 2024, Total Current Assets is likely to grow to about 82.2 M, while Other Assets are likely to drop 0.95.

Technical Drivers

As of the 30th of November, Actinium Pharmaceuticals shows the Risk Adjusted Performance of (0.06), standard deviation of 4.29, and Mean Deviation of 3.57. Actinium Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Actinium Pharmaceuticals market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Actinium Pharmaceuticals is priced correctly, providing market reflects its regular price of 1.44 per share. Please also double-check Actinium Pharmaceuticals jensen alpha, which is currently at (0.53) to validate the company can sustain itself at a future point.

Actinium Pharmaceuticals Price Movement Analysis

Actinium Pharmaceuticals Insider Trading Activities

Actinium Pharmaceuticals Outstanding Bonds

Actinium Pharmaceuticals Predictive Daily Indicators

Actinium Pharmaceuticals Forecast Models

Actinium Pharmaceuticals' time-series forecasting models are one of many Actinium Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Actinium Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Actinium Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Actinium shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Actinium Pharmaceuticals. By using and applying Actinium Stock analysis, traders can create a robust methodology for identifying Actinium entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Actinium analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Actinium analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Actinium Pharmaceuticals stock analysis indicators help investors evaluate how Actinium Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Actinium Pharmaceuticals shares will generate the highest return on investment. By understating and applying Actinium Pharmaceuticals stock analysis, traders can identify Actinium Pharmaceuticals position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Actinium Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Actinium Stock, please use our How to Invest in Actinium Pharmaceuticals guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Actinium Pharmaceuticals. If investors know Actinium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Actinium Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Actinium Pharmaceuticals is measured differently than its book value, which is the value of Actinium that is recorded on the company's balance sheet. Investors also form their own opinion of Actinium Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Actinium Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Actinium Pharmaceuticals' market value can be influenced by many factors that don't directly affect Actinium Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Actinium Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Actinium Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Actinium Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.